JP Morgan Chase
OSIR

JP Morgan Chase’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

JP Morgan Chase’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-56,807
Closed -$1.08M – 6220
2019
Q1 		$1.08M Buy
56,807
+33,424
+143% +$542K ﹤0.01% 3760
2018
Q4 		$316K Hold
23,383
– – ﹤0.01% 4368
2018
Q3 		$260K Buy
+23,383
New +$234K ﹤0.01% 4585
2016
Q3 		– Sell
-657
Closed -$3K – 5125
2016
Q2 		$3K Buy
+657
New +$3.54K ﹤0.01% 4586

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

JP Morgan Chase's OSIR Position: Q2 2019 in Review

JP Morgan Chase sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 56,807 shares — an estimated $1.08M sold.

JP Morgan Chase first reported a position in OSIR in Q2 2016 and held it in 4 quarters. The position peaked at $1.08M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • JP Morgan Chase reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • JP Morgan Chase sold 56,807 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.08M.
  • JP Morgan Chase first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2016 and held it in 4 quarters.
  • JP Morgan Chase's Osiris Therapeutics, Inc. Common Stock position peaked at $1.08M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.